AI and Insurtech are transforming workers’ compensation, but businesses shopping for new solutions need to know how to differentiate genuine innovation from fluff.
Major biometric damages claims are here to stay, and companies using biometric-based tech must watch out for new exclusions in their liability coverage.
Although they make up the single largest classification of work-related injuries, with proper commitment, employers can continue to make improvement in MSD injury rates.
For the past three years, we have been reacting to the macroeconomic environment as increased volatility and evolving risks provoke organizational concerns. Companies are looking for solutions that deliver sustainable predictability, and innovation, data & analytics may be the key.
Not too hot, not too cold – just right. It’s the philosophy Goldilocks applied to the three bears, and it’s the philosophy we should be utilizing when pulling together the best data set.
While automation can streamline many aspects of pension and retirement plan management and requires less manual input from the fiduciary, the digitization of these processes opens up new risks.
When third parties invest large sums in a lawsuit in exchange for a portion of the eventual settlement, it can affect the legal process — and the E&S market — in more ways than one.
Why does it appear that injuries sustained outside of work have more positive outcomes than the same injuries sustained on the job? There might be evidence in the physiology of humans that workers’ comp can not overlook.
Treating mental health in workers’ compensation claims can be tricky, particularly when we look at what individual states allow. But with a workers’ comp advocacy support system in place, these claims can be addressed long before potential litigation.
The IME cover letter is the single most important tool for the physician reviewer. Genex’s Donna Bradshaw outlines how to ensure yours are factual and complete.
Mission critical risk denial can be costly. Disappointment and anger will affect all aspects of the company’s operations — including recruitment and retention of employees, revenues, litigation and cost of capital.
AWP has been the source of litigation, challenges and legislation for decades. CMS no longer allows AWP to be used as a basis for pricing drugs under Medicare.